IE
BNTX icon

Israel Englander’s BioNTech BNTX Stock Holding History

Israel Englander’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
+3,000
New +$282K ﹤0.01% 5151
2026
Q1 		– Sell
-80,000
Closed -$7.62M – 5738
2025
Q4 		$7.62M Buy
+80,000
New +$8.06M ﹤0.01% 2557
2024
Q4 		– Sell
-50,200
Closed -$5.96M – 5968
2024
Q3 		$5.96M Buy
50,200
+5,200
+12% +$478K ﹤0.01% 2693
2024
Q2 		$3.62M Buy
45,000
+9,300
+26% +$850K ﹤0.01% 3025
2024
Q1 		$3.29M Buy
35,700
+12,800
+56% +$1.23M ﹤0.01% 3284
2023
Q4 		$2.42M Sell
22,900
-15,100
-40% -$1.52M ﹤0.01% 3447
2023
Q3 		$4.13M Sell
38,000
-2,900
-7% -$321K ﹤0.01% 2877
2023
Q2 		$4.41M Buy
40,900
+38,300
+1,473% +$4.31M ﹤0.01% 2780
2023
Q1 		$324K Buy
+2,600
New +$357K ﹤0.01% 4856

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Israel Englander's BNTX Position: Q2 2026 in Review

Israel Englander sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 35,372 shares — an estimated $3.33M sold.

Israel Englander first reported a position in BNTX in Q4 2019 and held it in 25 quarters. The position peaked at $84.6M in Q3 2021. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Israel Englander reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 35,372 BioNTech shares in Q2 2026, an estimated $3.33M.
  • Israel Englander first reported a position in BioNTech in Q4 2019 and held it in 25 quarters.
  • Israel Englander's BioNTech position peaked at $84.6M in Q3 2021.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.